Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 7Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Other solid neoplasm 1

Conditions

Uveal Melanoma 2Retinoblastoma 1Retinal Diseases 1Melanoma 1Macular Degeneration 1Choroid Diseases 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Ranibizumab × Clear all
NCT01899066 2014-05-13

Efficacy Study of Lucentis in the Treatment of Retinoblastoma

Sun Yat-sen University

Phase 2 Unknown
20 enrolled
Other solid neoplasm

Retinoblastoma

NCT00811200 2009-07-02

TORR

Leiden University Medical Center

Phase 2/3 Unknown
220 enrolled
Dermatologic

Uveal Melanoma, Macular Degeneration, Melanoma, Retinal Diseases, Choroid Diseases

NCT00540930 2007-10-08

Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

Shields, Shields and Associates

Phase 4 Unknown
400 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡